Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q3 2024 ▲▼ | Q4 2024 ▲▼ | Change ▲▼ | Q3 2024 ▲▼ | Q4 2024 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Nuvalent Inc | 5,000,000 | 5,363,379 | +363,379 | $511.50M | $419.85M | 14.61% | -$91.65M |
| Arcellx Inc COMMON STOCK | 4,000,000 | 4,371,601 | +371,601 | $334.04M | $335.26M | 11.66% | +$1.22M |
| argenx SEADR(ARGX) | 480,374 | 481,305 | +931 | $260.40M | $296.00M | 10.30% | +$35.60M |
| Revolution Medicines, Inc.(RVMD) | 5,314,089 | 6,553,111 | +1,239,022 | $240.99M | $286.63M | 9.97% | +$45.64M |
| Janux Therapeutics, Inc.(JANX) | 2,400,574 | 3,515,986 | +1,115,412 | $109.06M | $188.25M | 6.55% | +$79.19M |
| Tarsus Pharmaceuticals, Inc.(TARS) | 2,440,445 | 2,531,896 | +91,451 | $80.27M | $140.19M | 4.88% | +$59.92M |
| Edgewise Therapeutics, Inc.(EWTX) | 2,789,172 | 4,493,929 | +1,704,757 | $74.44M | $119.99M | 4.17% | +$45.54M |
| Vaxcyte, Inc.(PCVX) | 627,732 | 1,422,787 | +795,055 | $71.73M | $116.47M | 4.05% | +$44.74M |
| BeOne Medicines AGADR(ONC) | 200,336 | 616,024 | +415,688 | $44.98M | $113.79M | 3.96% | +$68.81M |
| Crinetics Pharmaceuticals In | 2,516,686 | 1,910,761 | -605,925 | $128.60M | $97.70M | 3.40% | -$30.91M |
| MoonLake ImmunotherapeuticsCL A(MLTX) | 931,480 | 1,772,211 | +840,731 | $46.97M | $95.97M | 3.34% | +$49.00M |
| Disc Medicine, Inc.(IRON) | 1,497,720 | 1,497,720 | 0 | $73.60M | $94.96M | 3.30% | +$21.36M |
| Merus N V | 2,454,917 | 1,689,922 | -764,995 | $122.65M | $71.06M | 2.47% | -$51.59M |
| Vera Therapeutics, Inc.CL A(VERA) | 1,096,851 | 1,437,339 | +340,488 | $48.48M | $60.79M | 2.11% | +$12.30M |
| Apogee Therapeutics Inc | 701,817 | 1,283,766 | +581,949 | $41.22M | $58.15M | 2.02% | +$16.93M |
| Olema Pharmaceuticals, Inc.(OLMA) | 5,503,600 | 7,304,970 | +1,801,370 | $65.71M | $42.59M | 1.48% | -$23.13M |
| Pliant Therapeutics, Inc.(PLRX) | 3,104,486 | 3,197,050 | +92,564 | $34.80M | $42.11M | 1.46% | +$7.30M |
| Immatics N.V.SHS(IMTX) | 3,904,862 | 5,414,409 | +1,509,547 | $44.55M | $38.50M | 1.34% | -$6.06M |
| Cogent Biosciences, Inc.(COGT) | 4,609,762 | 4,917,412 | +307,650 | $49.79M | $38.36M | 1.33% | -$11.43M |
| Spyre Therapeutics, Inc.(SYRE) | 1,267,581 | 1,527,205 | +259,624 | $37.28M | $35.55M | 1.24% | -$1.73M |
| Viridian Therapeutics, Inc.(VRDN) | 2,895,689 | 1,820,079 | -1,075,610 | $65.88M | $34.89M | 1.21% | -$30.99M |
| Y-Mabs Therapeutics Inc | 4,086,346 | 4,236,346 | +150,000 | $53.74M | $33.17M | 1.15% | -$20.56M |
| Erasca, Inc.(ERAS) | 10,668,141 | 10,752,354 | +84,213 | $29.12M | $26.99M | 0.94% | -$2.14M |
| Tectonic Therapeutic, Inc.(TECX) | 0 | 485,105 | +485,105 | $0 | $22.40M | 0.78% | +$22.40M |
| LENZ Therapeutics, Inc.(LENZ) | 0 | 770,455 | +770,455 | $0 | $22.24M | 0.77% | +$22.24M |
| Scholar Rock Holding Corporation(SRRK) | 0 | 400,000 | +400,000 | $0 | $17.29M | 0.60% | +$17.29M |
| Oruka Therapeutics, Inc.(ORKA) | 719,660 | 819,660 | +100,000 | $17.64M | $15.89M | 0.55% | -$1.75M |
| Agios Pharmaceuticals, Inc.(AGIO) | 0 | 276,439 | +276,439 | $0 | $9.08M | 0.32% | +$9.08M |
| Arvinas, Inc.(ARVN) | 2,339,961 | 0 | -2,339,961 | $57.63M | $0 | — | -$57.63M |
| COMPASS Pathways plcADS(CMPS) | 1,160,000 | 0 | -1,160,000 | $7.31M | $0 | — | -$7.31M |
| Cullinan Therapeutics, Inc.(CGEM) | 2,321,013 | 0 | -2,321,013 | $38.85M | $0 | — | -$38.85M |
| Immunovant, Inc.(IMVT) | 1,362,827 | 0 | -1,362,827 | $38.85M | $0 | — | -$38.85M |
| Keros Therapeutics, Inc.(KROS) | 525,037 | 0 | -525,037 | $30.49M | $0 | — | -$30.49M |
| Kura Oncology, Inc.(KURA) | 4,331,321 | 0 | -4,331,321 | $84.63M | $0 | — | -$84.63M |
| Perspective Therapeutics, Inc.(CATX) | 919,692 | 0 | -919,692 | $12.28M | $0 | — | -$12.28M |